The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop ... seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

The manufacturer of semaglutide, Novo Nordisk, plans to seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease ... would be just the second drug the FDA has approved for treatment of MASH. The first, a medication called ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy ... and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year ...